396
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Socio-demographic, lifestyle and psychological predictors of benzodiazepine and z-hypnotic use patterns

, , , , &
Pages 107-116 | Accepted 06 Feb 2013, Published online: 22 Mar 2013

References

  • Nilsen E, Bachs L, Bjørner T, Høiseth G, Johnsen J, Ørbeck AL, et al. Benzodiazepiner i behandling av personer med rusmiddelproblemer. [Benzodiazepines in treatment of people with substance use-related problems] (in Norwegian). Report from the Norwegian Knowledge Centre for the Health Services, 2007; no. 06.
  • Hartz I, Tverdal A, Skurtveit S. Langtidsbruk av benzodiazpiner i kombinasjon med opioider og z-hypnotika blant uføretrygdede i Norge. [Long-term use of combined benzodiazepine and z-hypnotic use among people who receive disability benefits in Norway] (in Norwegian). Norsk Farmaceutisk Tidsskrift 2011;4:24–28.
  • Mellingsæther TC, Bramness JG, Slørdal L. Er z-hypnotika bedre og tryggere sovemedisiner enn benzodiazepiner. [Are z-hypnotics better and safer sleeping medications than benzodiazepines?] (in Norwegian). Tidsskrift for Norsk Lægeforening 2006;126:2954–2960.
  • Verispan L Vector One: National (VONA) Health Analytics Data. 2008. Retrieved 22 August 2011, Substance Abuse and Mental Health Services Administration: http://nac.samhsa.gov/DTAB/Presentations/Aug08/SeanBelouinDTAB0808.ppt.
  • Greenblatt DJ, Harmatz JS, Shader RI. Psychotropic drug prescribing in the United States. J Clin Psychopharmacol 2011;31:1–3.
  • Moylan S, Staples J, Ward SA, Rogerson J, Stein DJ, Berk M. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder. J Clin Psychopharmacol 2011;31:647–652.
  • Lagnaoui R, Depont F, Fourrier A, Abouelfath A, Begaud B, Vedoux H, Moore N. Patterns and correlates of benzodiazepine use in the French general population. Eur J Clin Pharmacol 2004;60:523–529.
  • Buffett-Jerrott SE, Stewart SH. Cognitive and sedative effects of benzodiazepine use. Curr Pharmacol Design 2002;8:45–58.
  • Sylvestre MP, Abrahamowicz M, Capek R, Tamblyn R. Assessing the cumulative effects of exposure to selected benzodiazepines on the risk of fall-related injuries in the elderly. Int Psychogeriatr 2011;8:1–10.
  • Pariente A, Dartigues JF, Benichou J, Letenneur L, Moore N, Fourrier Reglat-A. Benzodiazepines and injurious falls in community dwelling elders. Drugs Aging 2008;25:61–70.
  • Smink B, Egberts A, Lusthof K, Uges D, de Gier J. The relationship between benzodiazepine use and traffic accidents: A systematic literature review. CNS Drugs 2010;24:639–653.
  • Griffiths RR, Weerts EM. Benzodiazepine self-administration in humans and laboratory animals—Implications for problems of long-term use and abuse. Psychopharmacology 1997;134:1–37.
  • Magrini N, Vaccheri A, Parma E, Allesandro RD, Bottoni A, Occhionero M, Montanaro N. Use of benzodiazepines in the Italian general population: Prevalence, pattern of use and risk factors for use. Eur J Clin Pharmacol 1996;50:19–25.
  • Bartlett G, Abrahamowicz M, Grad R, Sylvestre M-P, Tamblyn R. Association between risk factors for injurious falls and new benzodiazepine prescribing in elderly persons. BMC Family Pract 2009;10:1–8.
  • Fang S-Y, Chen C-Y, Chang IS, Wu CHE, Chang C-M, Lin K-M. Predictors of the incidence and discontinuation of long-term use of benzodiazepines: A population-based study. Drug Alcohol Depend 2009;104:140–146.
  • Van der Waals FW, Mohrs J, Foets M. Sex differences among recipients of benzodiazepines in Dutch general practice. BMJ 1993;307:363–366.
  • Isacson D. Long-term benzodiazepine use: Factors of importance and the development of individual use patterns over time—A 13-year follow-up in a Swedish community. Soc Sci Med 1997;44:1871–1880.
  • Mellinger GD, Balter MB, Uhlenhuth EH. Prevalence and correlates of the long-term regular use of anxiolytics. JAMA 1984;251: 375–379.
  • De Las Cuevas C, Sanz E, De la Fuente JA, Cabrera C, Mateos A. Prescribed daily doses and risk factors associated with the use of benzodiazepines in primary care. Pharmacoepidemiol Drug Safety 1999;8:207–216.
  • Blennow G, Romelsjö A, Leifman H, Leifman A, Karlsson G. Sedatives and hypnotics in Stockholm—Social factors and kinds of use. Am J Public Health 1994;84:242–246.
  • Vasile RG, Bruce SE, Goisman RB, Pagano M, Keller MB. Results of a naturalistic longitudinal study of benzodiazepine and SSRI use in the treatment of generalized anxiety disorder and social phobia. Depress Anxiety 2005;22:59–67.
  • Jorm AF, Grayson D, Creasey H, Waite L, Broe GA. Long term benzodiazepine use by elderly people living in the community. Aus N Z J Public Health 2000;24:7–10.
  • Brunette MF, Noordsy DL, Xie H, Drake RF. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders. Psychiat Serv 2003;54: 1395–1401.
  • Hausken AM, Furu K, Tverdal A, Skurtveit S. Mental distress and subsequent use of anxiolytic drugs: A prospective population- based cohort study of 16.000 individuals. J Public Health 2010;38:465–473.
  • Nutt D. Anxiety and depression: Individual entities or two sides of the same coin?Int J Psychiatry Clin Pract 2004;8:19–24.
  • Holmen J, Midthjell K, Krüger Ø, Langhammer A, Holmen TL, Bratberg GH, et al. The Nord-Trøndelag health study 1995–97 (HUNT 2): Objectives, contents, methods and participation. Norsk Epidemiol 2003;13:19–32.
  • Madhusoodanan S, Bogunovic OJ. Safety of benzodiazepines in the geriatric population. Expert Opin Drug Safety 2004;3: 485–493.
  • World Health Organisation 2011 WHO Collaborating Centre for Drug Statistics Methodology. Retrieved 21.11.2011 http://www.whocc.no/
  • Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiat Scand 1983;67:361–370.
  • Martin CR. What does the Hospital Anxiety and Depression Scale (HADS) really measure in Liaison psychiatry settings?Curr Psychiat Rev 2005;1:69–73.
  • Mykletun A, Bjerkeset O, Øverland S, Prince M, Dewey M, Stewart R. Levels of anxiety and depression as predictors of mortality: The HUNT study. Br J Psychiatry 2009;195:118–125.
  • Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res 2002;52:69–77.
  • Søgaard AJ, Bjelland I, Tell GS, Røysamb E. A comparison of the CONOR Mental Health Index to the HSCL-10 and HADS. Measuring mental health status in the Oslo health study and the Nord-Trøndelag health study. Norsk Epidemiol 2003;13:279–284.
  • Rosenberg M. Society and the adolescent self-image. Princeton, NJ: Princeton University Press; 1965.
  • Rosenberg M. Society and the adolescent self-image, revised edition. Middletown, CT: Wesleyan University Press; 1989.
  • Ewing JA. Detecting alcoholism: The CAGE Questionnaire. JAMA 1984;252:1905–1907.
  • Buchsbaum DG, Buchanan RG, Centor RM, Schnoll SH, Lawton MJ. Screening for alcohol abuse using CAGE scores and likelihood ratios. Ann Internal Med 1991;155:774–777.
  • Mayfield D, McLeod G, Hall P. The Cage questionnaire: Validation of a new alcoholism screening instrument. Am J Psychiatry 1974;131:1121–1123.
  • Wu S-I, Huang H-C, Liu S-I, Huang C-R, Sun F-J, Chang T-Y, et al. Validation and comparison of alcohol screening instruments for identifying hazardous drinking in hospitalized patients in Taiwan. Alcohol Alcoholism 2008;43:577–582.
  • Nunnally JC. Psychometric theory. New York: McGraw-Hill;1978
  • Hair JF, Anderson RE, Tatham RL, Black WC. Multivariate data analysis. Upper Saddle River, NJ: Prentice-Hall; 1998.
  • Hollingworth S, Siskind D. Anxiolytic, hypnotic and sedative medication use in Australia. Pharmacoepidemiol Drug Safety 2010;19:280–288.
  • O’Brien CP. Benzodiazepine use, abuse, and dependence. J Clin Psychiatry 2005;66:28–33.
  • Landi F, Onder G, Cesari M, Barillaro C, Russo A, Bernabei R. Psychotropic medications and risk for falls among community-dwelling frail older people: An observational study. J Gerontol Ser A: Biol Sci Med Sci 2005;60:622–626.
  • Gallacher J, Elwood P, Pickering J, Bayer A, Fish M, Ben-Shlomo Y. J Epidemiol Community Health 2012;66:869–873.
  • Mirowsky J, Ross CE. Education, social status and health. New York: Walter de Gruyter Inc; 2003.
  • Williams LJ, Brennan SL, Henry MJ, Berk M, Jacka FN, Nicholson GC, Kotowicz MA, Pasco JA. Area-based socioeconomic status and mood disorders: Cross-sectional evidence from a cohort of randomly selected adult women. Maturitas 2011;69:173–178.
  • Baldwin D, Woods R, Lawson R, Taylor D. Efficacy of drug treatments for generalised anxiety disorder: Systematic review and meta-analysis. BMJ 2011;342:1–11.
  • Salminen S, Heiskanen M. Correlations between traffic, occupational, sports and home accidents. Accident Anal Prev 1997;29:33–36.
  • Tada A, Matsukubo T. Relationship between oral health behaviours and general health behaviours in a Japanese adult population. J Public Health Dentistry 2003;63:250–254.
  • Slutske WS, Heath AC, Madden PAF, Bucholz KK, Statham DJ, Martin NG. Personality and genetic risk for alcohol dependence. J Abnorm Psychol 2002;111:124–133.
  • Zevin S, Benowitz NL. Drug interactions with tobacco smoking. An update. Clin Pharmacokinetics 1999;36:425–438.
  • Fox KR. The influence of physical activity on mental well-being. Public Health Nutr 1999;2:411–418.
  • Torvik FA, Rognmo K, Tambs K. Alcohol use and mental distress as predictors of non-response in a general population health survey: The HUNT study. Soc Psychiatry Psychiatr Epidemiol 2012;47:805–816.
  • Langhammer A, Johnsen R, Holmen J, Gulsvik A, Bjermer L. Cigarette smoking gives more respiratory symptoms among women than among men. The Nord-Trondelag Health Study (HUNT). J Epidemiol Community Health 2000;54:917–922.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.